New IV stopper aims to cut catheter complications in hospitals
NCT ID NCT07519304
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a needle-free connector with anti-reflux technology, a special stopper that prevents blood from flowing back into IV catheters. The goal is to see if it reduces complications like blockages, infections, and pain compared to standard connectors. The trial will involve 62 hospitalized adults who need a long peripheral catheter for at least a week.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Needle-free connector with anti-reflux technology (Clave™ Neutron™)
What this could lead to
If it works, this could reduce catheter-related complications such as blockages, infections, and pain, improving patient comfort and safety during hospital stays.
What could go wrong
This is a small early-stage trial with only 62 participants, so results may not apply to all patients. The device may not significantly reduce complications compared to standard connectors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RANDOMISED CONTROLLED TRIAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••